BC Archives - Page 3 of 3 - ME Therapeutics Inc.

Oct 2023

ME THERAPEUTICS HOLDINGS INC. Announces Listing And Trading Of Its Common Shares On The Canadian Securities Exchange

ME Therapeutics Holdings Inc. (CSE: METX) (the “Company” or “MET”), a preclinical stage biotechnology company working on novel cancer fighting drugs

BC, VANCOUVER

Mar 2023

ME THERAPEUTICS INC. Publishes Research On The Role Of G-CSF In Breast And Colorectal Cancer In Cancer Research Communications

ME Therapeutics Inc., a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of Immuno-Oncology, is pleased

BC, VANCOUVER

Mar 2023

ME THERAPEUTICS INC. Announces The Grant Of A Chinese Patent On Their Lead G-CSF Antibody Candidate

ME Therapeutics Inc., a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of Immuno-Oncology, is pleased

NEWS

Company news and the latest scientific findings

ME THERAPEUTICS HOLDINGS INC. Announces Listing And Trading Of Its Common Shares On The Canadian Securities Exchange

ME THERAPEUTICS INC. Publishes Research On The Role Of G-CSF In Breast And Colorectal Cancer In Cancer Research Communications

ME THERAPEUTICS INC. Announces The Grant Of A Chinese Patent On Their Lead G-CSF Antibody Candidate

Check out our profile on SEDAR+

ME THERAPEUTICS ATTENDING JP MORGAN HEALTHCARE CONFERENCE

ME THERAPEUTICS GRANTED LICENCE FOR CD22 NANOBODY ASSET TO EXPAND NEXT-GEN IN VIVO CAR CELL THERAPY PROGRAM

ME THERAPEUTICS ADDED TO CSE25 INDEX

ME THERAPEUTICS SECURES U.S. PATENT FOR LEAD CANDIDATE AND ADVANCES BROADER THERAPEUTIC PROGRAMS

ME THERAPEUTICS RECEIVES SUPPORT TO ADVANCE mRNA THERAPEUTIC CANDIDATES FOR CANCER AND INFLAMMATORY DISEASE

ME THERAPEUTICS ANNOUNCES IT HAS ENGAGED LUCOSKY BROOKMAN LLP TO EXPLORE A LISTING ON THE NASDAQ OR NYSE

ME THERAPEUTICS ANNOUNCES THAT ITS FIRST THERAPEUTIC MRNA CANDIDATE SHOWS ENCOURAGING ANTI-CANCER EFFICACY IN VIVO

ME THERAPEUTICS HOLDINGS INC. APPOINTS CHIEF BUSINESS OFFICER

ME THERAPEUTICS HOLDINGS INC. PROVIDES RESEARCH AND DEVELOPMENT UPDATE AND CORPORATE UPDATE

ME THERAPEUTICS ANNOUNCES THE START OF TESTING OF FIRST MRNA FORMULATIONS FROM NANOVATION THERAPEUTICS COLLABORATION

ME THERAPEUTICS ANNOUNCES NEW COLLABORATION WITH NANOVATION THERAPEUTICS ON ADVANCED THERAPEUTIC MRNA DELIVERY TO MYELOID CELLS

ME THERAPEUTICS HOLDINGS INC. ANNOUNCES THE ADDITION OF TWO NEW CLINICAL CONSULTANTS TO CONTINUE THE ADVANCEMENT OF OUR LEAD ANTI-G-CSF ANTIBODY CANDIDATE TOWARDS A FIRST-IN-HUMAN CLINICAL TRIAL

ME THERAPEUTICS TO PRESENT AT INVESTOR CLUBHOUSE AT THE CANADIAN OPEN AND ATTEND THE 2024 BIO INTERNATIONAL CONVENTION FOR PARTNERING OPPORTUNITIES

ME THERAPEUTICS ANNOUNCES UPCOMING PARTICIPATION IN THE 2024 BLOOM BURTON & CO HEALTH CARE CONFERENCE AND INTERVIEW ON CSE TV

ME THERAPEUTICS ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT

ME THERAPEUTICS ANNOUNCES NON-BROKERED PRIVATE PLACEMENT AND PROVIDES CORPORATE UPDATE

ME THERAPEUTICS HOLDINGS INC. PROVIDES CORPORATE UPDATES

ME THERAPEUTICS HOLDINGS INC. ANNOUCES LISTING ON THE FRANKFURT STOCK EXCHANGE (FSE) AND THE COMPLETION OF ITS REDESIGNED WEBSITE

ME THERAPEUTICS HOLDINGS INC. Provides An Overview And Update On Current Research And Development Programs

ME THERAPEUTICS HOLDINGS INC. Receives Funding Support For Preclinical Testing Of Prodrug Candidates

ME THERAPEUTICS HOLDINGS INC. Announces Listing And Trading Of Its Common Shares On The Canadian Securities Exchange

ME THERAPEUTICS INC. Publishes Research On The Role Of G-CSF In Breast And Colorectal Cancer In Cancer Research Communications

ME THERAPEUTICS INC. Announces The Grant Of A Chinese Patent On Their Lead G-CSF Antibody Candidate

Keep up to date by subscribing to our mailing list

Links

Social

Get In Touch

ME Therapeutics
2665 East Mall
Room 249
Vancouver, BC
V6T 1Z4

NEWS

Company news and the latest scientific findings

Check out our profile on SEDAR+

Keep up to date by subscribing to our mailing list

Links

Social

Get In Touch

ME Therapeutics 2665 East MallRoom 249Vancouver, BCV6T 1Z4

ME Therapeutics
2665 East Mall
Room 249
Vancouver, BC
V6T 1Z4